Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes

Stem Cell Research

Volumn 6, Issue 1, 2011, Pages 60-69

  Santourlidis, Simeon ^a   Wernet, Peter ^a   Ghanjati, Foued ^a   Graffmann, Nina ^a   Springer, Judith ^a   Kriegs, Christian ^a   Zhao, Xiaoyi ^a   Brands, Jens ^a   Araúzo Bravo, Marcos Jesus ^b   Neves, Rui ^a   Koegler, Gesine ^a   Uhrberg, Markus ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; ENHANCER REGION; EPIGENETICS; FEMALE; GENE; GENE REPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; SOMATIC CELL GENETICS; STEM CELL; UMBILICAL CORD BLOOD; UNRESTRICTED SOMATIC STEM CELL;

CELL DIFFERENTIATION; CELLS, CULTURED; DNA METHYLATION; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS;

EID: 78649514476     PISSN: 18735061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scr.2010.08.003     Document Type: Article

References (44)

1. Aktas M., Buchheiser A., Houben A., Reimann V., Radke T., Jeltsch K., Maier P., Zeller W.J., Kogler G. Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood. Cytotherapy 2010, 12(3):338-348.
2. Amabile G., Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol. Med. 2009, 15(2):59-68.
3. Antequera F., Boyes J., Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990, 62(3):503-514.
4. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001, 410(6824):120-124.
5. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., Feil R., Schreiber S.L., Lander E.S. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125(2):315-326.
6. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16(1):6-21.
7. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., Jaenisch R., Young R.A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122(6):947-956.
8. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113(5):643-655.
9. Chambers I., Silva J., Colby D., Nichols J., Nijmeijer B., Robertson M., Vrana J., Jones K., Grotewold L., Smith A. Nanog safeguards pluripotency and mediates germline development. Nature 2007, 450(7173):1230-1234.
10. Choi J.H., Park S.H., Park J., Park B.G., Cha S.J., Kong K.H., Lee K.H., Park A.J. Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma. Biochem. Biophys. Res. Commun. 2007, 361(3):615-620.
11. Ferri A.L., Cavallaro M., Braida D., Di Cristofano A., Canta A., Vezzani A., Ottolenghi S., Pandolfi P.P., Sala M., DeBiasi S., Nicolis S.K. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 2004, 131(15):3805-3819.
12. Gan Q., Yoshida T., McDonald O.G., Owens G.K. Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 2007, 25(1):2-9.
13. Gidekel S., Bergman Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 2002, 277(37):34521-34530.
14. Guilleret I., Benhattar J. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Biochem. Biophys. Res. Commun. 2004, 325(3):1037-1043.
15. Guilleret I., Yan P., Grange F., Braunschweig R., Bosman F.T., Benhattar J. Hypermethylation of the human telomerase catalytic subunit(hTERT) gene correlates with telomerase activity. Int. J. Cancer 2002, 101(4):335-341.
16. Harris D.T. Non-haematological uses of cord blood stem cells. Br. J. Haematol. 2009, 147(2):177-184.
17. Hattori N., Imao Y., Nishino K., Hattori N., Ohgane J., Yagi S., Tanaka S., Shiota K. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. Genes Cells 2007, 12(3):387-396.
18. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293(5532):1074-1080.
19. Kluth S.M., Buchheiser A., Houben A.P., Geyh S., Krenz T., Radke T.F., Wiek C., Hanenberg H., Reinecke P., Wernet P., Kögler G. DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev. 2010, 23.
20. Kögler G., Callejas J., Hakenberg P., Enczmann J., Adams O., Daubener W., Krempe C., Gobel U., Somville T., Wernet P. Hematopoietic transplant potential of unrelated cord blood: critical issues. J. Hematother. 1996, 5(2):105-116.
21. Kögler G., Sensken S., Airey J.A., Trapp T., Müschen M., Feldhahn N., Liedtke S., Sorg R.V., Fischer J., Rosenbaum C., Greschat S., Knipper A., Bender J., Degistirici O., Gao J., Caplan A.I., Colletti E.J., Almeida-Porada G., Müller H.W., Zanjani E., Wernet P. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 2004, 200(2):123-135.
22. Kögler G., Sensken S., Wernet P. Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp. Hematol. 2006, 34(11):1589-1595.
23. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128(4):693-705.
24. Liedtke S., Buchheiser A., Bosch J., Bosse F., Kruse F., Zhao X., Santourlidis S., Kögler G. The HOX Code as a "biological fingerprint" to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Res. 2010, 5(1):40-50.
25. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., Ko M.S., Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 2007, 9(6):625-635.
26. Meissner A., Mikkelsen T.S., Gu H., Wernig M., Hanna J., Sivachenko A., Zhang X., Bernstein B.E., Nusbaum C., Jaffe D.B., Gnirke A., Jaenisch R., Lander E.S. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454(7205):766-770.
27. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
28. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113(5):631-642.
29. Miyagi S., Nishimoto M., Saito T., Ninomiya M., Sawamoto K., Okano H., Muramatsu M., Oguro H., Iwama A., Okuda A. The Sox2 regulatory region 2 functions as a neural stem cell-specific enhancer in the telencephalon. J. Biol. Chem. 2006, 281(19):13374-13381.
30. Mutskov V., Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 2004, 23:138-149.
31. Nakayama J., Rice J.C., Strahl B.D., Allis C.D., Grewal S.I. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 2001, 292(5514):110-113.
32. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24(4):372-376.
33. Noma K., Allis C.D., Grewal S.I. Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries. Science 2001, 293(5532):1150-1155.
34. Paz M.F., Fraga M.F., Avila S., Guo M., Pollan M., Herman J.G., Esteller M. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res. 2003, 63(5):1114-1121.
35. Plath K., Fang J., Mlynarczyk-Evans S.K., Cao R., Worringer K.A., Wang H., de la Cruz C.C., Otte A.P., Panning B., Zhang Y. Role of histone H3 lysine 27 methylation in X inactivation. Science 2003, 300(5616):131-135.
36. Ratajczak M.Z., Zuba-Surma E.K., Shin D.M., Ratajczak J., Kucia M. Very small embryonic-like(VSEL) stem cells in adult organs and their potential role in rejuvenation of tissues and longevity. Exp. Gerontol. 2008, 43(11):1009-1017.
37. Santourlidis S., Trompeter H.I., Weinhold S., Eisermann B., Meyer K.L., Wernet P., Uhrberg M. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 2002, 169(8):4253-4261.
38. Santourlidis S., Graffmann N., Christ J., Uhrberg M. Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells. J. Immunol. 2008, 180(1):418-425.
39. Shay J.W., Wright W.E. Telomeres and telomerase in normal and cancer stem cells. FEBS Lett. 2010, 584(17):3819-3825.
40. Sikorska M., Sandhu J.K., Deb-Rinker P., Jezierski A., Leblanc J., Charlebois C., Ribecco-Lutkiewicz M., Bani-Yaghoub M., Walker P.R. Epigenetic modifications of SOX2 enhancers, SRR1 and SRR2, correlate with in vitro neural differentiation. J. Neurosci. Res. 2008, 86(8):1680-1693.
41. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
42. Yuan H., Corbi N., Basilico C., Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995, 9(21):2635-2645.
43. Zaehres H., Kögler G., Arauzo-Bravo M.J., Bleidissel M., Santourlidis S., Weinhold S., Greber B., Kim J.B., Buchheiser A., Liedtke S., Eilken H.M., Graffmann N., Zhao X., Meyer J., Reinhardt P., Burr B., Waclawczyk S., Ortmeier C., Uhrberg M., Schöler H.R., Cantz T., Wernet P. Induction of pluripotency in human cord blood unrestricted somatic stem cells. Exp. Hematol. 2010, 38(9):809-818.
44. Zaehres H., Kim J.B., Schöler H.R. Induced pluripotent stem cells. Methods Enzymol. 2010, 476C:309-325.